Glossary

ADHD and Medical Cannabis

ADHD (Attention Deficit Hyperactivity Disorder) is a neurodevelopmental condition that may qualify for medical cannabis treatment in the UK when conventional therapies have been insufficient.

Key Takeaways

  • ADHD is one of the qualifying conditions for medical cannabis in the UK

  • Medical cannabis may help manage ADHD-related symptoms such as difficulty concentrating, restlessness, and sleep disruption

  • Patients must have tried conventional ADHD treatments first (e.g. methylphenidate, lisdexamfetamine) before being considered

  • A specialist doctor assesses each case individually — medical cannabis is not suitable for everyone with ADHD

What Is ADHD?

ADHD is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity, and impulsivity that affect daily functioning. According to the NHS, ADHD affects around 3–4% of adults in the UK. Conventional treatments include stimulant medications (methylphenidate, lisdexamfetamine), non-stimulant medications, and behavioural therapy.

Can Medical Cannabis Help with ADHD?

Some patients report that medical cannabis may help manage ADHD-related symptoms, particularly difficulty sleeping, anxiety, and restlessness. However, the evidence base is still developing. Patients considering medical cannabis for ADHD should discuss options with a specialist who can evaluate their individual circumstances.

How to Access Treatment

To be eligible for medical cannabis for ADHD, patients must have tried at least two conventional treatments without adequate symptom relief. Use our medical cannabis eligibility checker to find out if you qualify, or learn more about qualifying conditions.

For comprehensive information on ADHD treatment with medical cannabis — including the evidence, how to qualify, and what to expect — see our dedicated page: ADHD Medical Cannabis Treatment UK.

Further Reading